Synergy between sublethal doses of shikonin and metformin fully inhibits breast cancer cell migration and reverses epithelial-mesenchymal transition

被引：0
作者：
Abolfazl Rostamian Tabari
Pegah Gavidel
Farzaneh Sabouni
Mossa Gardaneh
机构：
[1] National Institute of Genetic Engineering and Biotechnology,
来源：
Molecular Biology Reports | 2022年 / 49卷
关键词：
Shikonin; Metformin; Breast cancer; MCF-7; Migration; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4307 / 4319
页数：12
相关论文
共 166 条
  • [1] DeSantis CE(2016)Breast cancer statistics, 2015: convergence of incidence rates between black and white women CA Cancer J Clin 66 31-42
  • [2] Fedewa SA(2014)Tumour heterogeneity and the evolution of polyclonal drug resistance Mol Oncol 8 1095-1111
  • [3] Goding Sauer A(2019)A view on drug resistance in cancer Nature 575 299-309
  • [4] Kramer JL(2001)Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells Br J Dermatol 144 745-750
  • [5] Smith RA(2017)EMT, CSCs, and drug resistance: the mechanistic link and clinical implications Nat Rev Clin Oncol 14 611-629
  • [6] Jemal A(2016)Cancer drug resistance redox resetting renders a way Oncotarget 7 42740-42761
  • [7] Burrell RA(2018)Cancer Stem Cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment Stem Cells Int 2018 5416923-1812
  • [8] Swanton C(2014)Cancer stem cells and tumor metastasis Int J Oncol 44 1806-482
  • [9] Vasan N(2011)Cancer stem cells and angiogenesis Int J Dev Biol 55 477-119
  • [10] Baselga J(2014)Cancer wars: natural products strike back Front Chem 2 20-27
12345678910